{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-057486","form_type":"8-K/A","ticker":"DRIO","cik":"0001533998","company_name":"DarioHealth Corp.","filed_at":"2023-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.296299+00:00","generated_at":"2026-06-15T08:59:49.791158+00:00","sec_items":["1.01","1.02","2.03","3.02","5.03","8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"DarioHealth amends 8-K; clarifies warrant & Series A-1 shares; closed $15.4M equity & $30M loan","bullets":["Raised $15.4M gross from sale of Series B, B-1, B-2, B-3 Preferred Stock at $1,000 per share.","Secured $30M initial tranche from Avenue Venture's $40M credit facility; interest at higher of (prime+4.5%) or 12.5%.","Issued lenders warrants for 584,884 shares at $3.334/share, 5-year term; terms clarified in this amendment.","Terminated prior OrbiMed credit agreement upon funding of new loan facility.","Series A-1 holders can earn up to 382,050 additional common shares for deferring conversion; reduced number clarified."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-057486","json":"https://secwatch.observer/filing/0001104659-23-057486.json","markdown":"https://secwatch.observer/filing/0001104659-23-057486.md","text":"https://secwatch.observer/filing/0001104659-23-057486.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533998/000110465923057486/0001104659-23-057486-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533998/000110465923057486/tm2315045d1_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T08:59:49.791158+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"54d11fc217bc03bb225bb74235b0aaf67618c1f3","claim":"DarioHealth Corp.: Filed Certificates of Designation for Series B, B-1, and B-2 Preferred Stock (effective 2023-05-01).","evidence_excerpt":"On May 1, 2023, the Company filed the Series B Certificate of Designation, designating 30,000 shares of Series B Preferred Stock, the Series B-1 Certificate of Designation, designating 15,000 shares of Series B-1 Preferred Stock, and the Series B-2 Certificate of Designation, designating 15,000 shares of Series B-2 Preferred Stock in connection with the Offering.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465923057486/0001104659-23-057486-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-05-01"}],"fact_type":"governance_change"},{"claim_id":"d358ff48357667c30133a12c1dd3fc1b889c4aea","claim":"DarioHealth Corp.: Filed Certificate of Designation for Series B-3 Preferred Stock (effective 2023-05-05).","evidence_excerpt":"On May 5, 2023, the Company filed the Series B-3 Certificate of Designation, designating 15,000 shares of Series B-3 Preferred Stock in connection with the Offering.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465923057486/0001104659-23-057486-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-05-05"}],"fact_type":"governance_change"},{"claim_id":"217511f47ae65bfdab3322830642e9d6018b6402","claim":"DarioHealth Corp. entered into Series B Purchase Agreement with accredited investors (effective 2023-05-01).","evidence_excerpt":"On May 1, 2023, DarioHealth Corp. (the “Company”) entered into securities purchase agreements (each, a “Series B Purchase Agreement”) with accredited investors relating to an offering (the “Offering”) and the sale of an aggregate of 6,200 shares of newly designated Series B Preferred Stock (the “Series B Preferred Stock”), an aggregate of 7,946 shares of Series B-1 Preferred Stock (the “Series B-1 Preferred Stock”), and an aggregate of 150 shares of Series B-2 Preferred Stock (the “Series B-2 Preferred Stock”) at a purchase price of $1,000 for each share of Preferred Stock.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465923057486/0001104659-23-057486-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"accredited investors"},{"label":"Effective","value":"2023-05-01"}],"fact_type":"material_agreement"},{"claim_id":"a33404f058b71983f2690f2362993ef6a9c71bb1","claim":"DarioHealth Corp. entered into Series B-3 Purchase Agreement with accredited investors (effective 2023-05-05).","evidence_excerpt":"On May 5, 2023, the Company entered into purchase agreements (the “Series B-3 Purchase Agreement” and together with the Series B Purchase Agreement, the “Purchase Agreement”) with accredited investors, relating to the Offering, to an offering and the sale of an aggregate of 1,106 shares of newly designated Series B-3 Preferred Stock (the “Series B-3 Preferred Stock” and, collectively with the Series B Preferred Stock, the Series B-1 Preferred Stock and the Series B-2 Preferred Stock, the “Preferred Stock”), at a purchase price of $1,000 for each share of Preferred Stock.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1533998/000110465923057486/0001104659-23-057486-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"accredited investors"},{"label":"Effective","value":"2023-05-05"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}